menu

HCC

Podcasts

cardImg

HCC - New Paradigms in Management

04/16/2025

Join Dr. Robert Wong, from Stanford University, Dr. Laura Kulik, from Northwestern, and Dr. Parissa Tabrizian, from Mount Sinai, for an expert discussion on hepatocellular carcinoma (HCC) and the evolving treatment landscape. This high-impact conversation explores how immune checkpoint inhibitors have transformed first-line systemic therapy for HCC, the integration of local regional treatments like Y90 radioembolization, and the growing role of combination strategies, including immunotherapy plus TACE or TKIs. The panel dives into personalized approaches to HCC management, including novel biomarkers, radiomics, and future applications of AI and ctDNA for better patient stratification.

The discussion also highlights expanding liver transplant eligibility through downstaging protocols and the safe use of immunotherapy in pre-transplant settings, as well as the resurgence of living donor liver transplantation. Plus, hear insights into the challenges of post-resection adjuvant therapy and the future of clinical trials in bridging systemic and curative-intent therapies. A must-watch for hepatologists, transplant surgeons, oncologists, and liver disease specialists aiming to stay at the forefront of HCC innovation.
View All Podcasts arrow

Publications

View All Modules arrow
pcbimg

Hepatocellular Carcinoma (HCC) Surveillance Beyond the Guidelines:

07/01/2024

Abstract Library

Unlocking Boundless Knowledge Through Abstracts

View All Modules arrow
alcbimg

Impact of MELD 3.0 Score on Outcomes After Combined Heart-Liver Transplantation: A UNOS Database Analysis.

10/01/2026

Esmailian Gabriel (G);Ganguli Sangrag (S);Jiang Richard (R);Lobo Alejandro Alvarez (AA);Jawitz Oliver (O);Goel Divyam (D);Patel Chetan (C);DeVore Adam (A);Russell Stuart (S);Kappus Matthew (M);King Lindsay (L);Knechtle Stuart (S);Sudan Debra (D);Keenan Jeffrey (J);Schroder Jacob (J);Milano Carmelo (C)

alcbimg

Drug-Induced Ductopenia in Two Prospective Registries: Favourable Outcomes and Late Recovery Despite Prolonged Cholestasis.

11/01/2026

Bessone Fernando (F);Hernandez Nelia (N);Schinoni Maria Isabel (MI);Brahm Javier (J);Medina-Caliz Inmaculada (I);Chiodi Daniela (D);Robles-Díaz Mercedes (M);Alvarez-Alvarez Ismael (I);Niu Hao (H);Cortese Mercedes (M);Tanno Hugo (H);Reggiardo Maria Virginia (MV);Tanno Federico (F);Paraná Raymundo (R);Fassio Eduardo (E);Jimenez Andrea (A);Lucena Maria Isabel (MI);Andrade Raul Jesus (RJ)

alcbimg

A Single Center Retrospective Study: Efficacy and Platelet Preservation of Double Plasma Molecular Adsorption System Therapy by Membrane Separation Versus Centrifugal Separation in Acute-on-Chronic Liver Failure Patients With Hepatocellular Carcinoma.

10/01/2026

Zhang Guozhen (G);Wu Yalin (Y);Li Xia (X);Zheng Hong (H);Guan QingPei (Q);Hao BoWei (B);Deng YueYang (Y);Zhang HaoXin (H);Wang Jing (J);Xia Rui (R)